Tower Trust & Investment Company’s AbbVie ABBV Stock Holding History

Tower Trust & Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Hold	1,020	–	–	0.16%	87
2026 Q1	$222K	Hold	1,020	–	–	0.15%	90
2025 Q4	$233K	Buy	1,020 +320	+46%	+$72.9K	0.15%	91
2025 Q3	$162K	Hold	700	–	–	0.11%	93
2025 Q2	$130K	Hold	700	–	–	0.09%	102
2025 Q1	$137K	Buy	+700	New	+$136K	0.11%	97

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Tower Trust & Investment Company's ABBV Position: Q2 2026 in Review

Tower Trust & Investment Company held its AbbVie (ABBV) position steady in Q2 2026 at 1,020 shares worth $257K. The position accounts for 0.16% of the portfolio, ranked #87.

Tower Trust & Investment Company first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tower Trust & Investment Company held 1,020 shares of AbbVie worth $257K as of Q2 2026.
Tower Trust & Investment Company left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.16% of Tower Trust & Investment Company's portfolio in Q2 2026, its #87 holding.
Tower Trust & Investment Company first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.